Commercial newswire·DE·
フレン・ヘルス、次世代の創傷治療用組換え酵素の製造に、AGCバイオロジクスを選定
ハイデルベルク拠点が、第II相試験に向けたラクトペルオキシダーゼおよびグルコースオキシダーゼのGMP開発を主導 ハイデルベルク拠点が、第II相試験に向けたラクトペルオキシダーゼおよびグルコースオキシダーゼのGMP開発を主導
Short extract only — this publisher licenses its text. Read the full release at the source.
More from Commercial newswire
- Form 8.3 - GAMMA COMMUNICATIONS PLC
- Africa Meal Kit Market Outlook 2026-2032 | Urbanization, Convenience and Demand for Home-Cooked Meals Drive New Opportunities
- Global Horse Racing Market 2026-2031: Digital Wagering, Live Streaming and Sponsorship Opportunities Drive Growth
The rest of this wire is for subscribers
Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
7 days, no card required.
Read releases like this the second they cross the wire.
1,400+ feeds — live on PPN World right now. Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live here.
PPN Source →Shared via PPN World — real-time press release intelligence.